UB Paderborn / Katalog / Suche / in CDI

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

The New England journal of medicine, 2021-04, Vol.384 (17), p.1589-1600

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study

Sexually transmitted diseases, 2019-05, Vol.46 (5), p.279-286

2019

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

The American heart journal, 2021-05, Vol.235, p.1-11

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study

Sexually transmitted diseases, 2019-01

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure

Nuclear medicine communications, 2017-02, Vol.38 (2), p.141-148

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract PR006: Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody

Cancer research (Chicago, Ill.), 2022-11, Vol.82 (22_Supplement), p.PR006-PR006

2022

Link zum Volltext

Verfügbarkeit prüfen

470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

Open forum infectious diseases, 2019-10, Vol.6 (Supplement_2), p.S230-S230

2019

Link zum Volltext

Verfügbarkeit prüfen

2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S708-S708

2018

Link zum Volltext

Verfügbarkeit prüfen

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S708-S708

2018

Link zum Volltext

Verfügbarkeit prüfen

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S533-S533

2017

Link zum Volltext

Verfügbarkeit prüfen

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S532-S532

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S533-S533

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of Delafloxacin (DLX) and Vancomycin/Aztreonam (VAN/AZ) on Resolution of Signs and Symptoms of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S531-S532

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Digital Versus Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement

JAMA : the journal of the American Medical Association, 2019-07, Vol.322 (4), p.349

2019

Link zum Volltext

Verfügbarkeit prüfen

Deformation behavior of aluminum alloy 6111-T4

Tseng, Carol

2000

Link zum Volltext
ProQuest

Smart Contact Lenses: Improving the Vision of Millions

Information display (1975), 2022-01, Vol.38 (1), p.36-37

Tseng, Carol

2022

Link zum Volltext

Verfügbarkeit prüfen

Building a Display Field Leader: SKL's Journey

Information display (1975), 2021-07, Vol.37 (4), p.40-42

Tseng, Carol

2021

Link zum Volltext

Verfügbarkeit prüfen

Student Earns Jsid Award For Work On Lcs For Ar Applications

Information display (1975), 2021-05, Vol.37 (3), p.47-47

Tseng, Carol

2021

Link zum Volltext

Verfügbarkeit prüfen

Likelihood Transformations and Artificial Mixtures

Statistical Modeling for Biological Systems, p.191-209

Link zum Volltext

Verfügbarkeit prüfen

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors

ChemMedChem, 2021-03, Vol.16 (6), p.942-948

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2021-05, Vol.325 (19), p.1965

2021

Link zum Volltext

Verfügbarkeit prüfen

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (10), p.962

2021

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

Journal of general internal medicine : JGIM, 2019-11, Vol.34 (11), p.2652-2659

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

Efficacy and Safety of Single-Dose Oral Delafloxacin Compared With Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study

Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics

Efficacy and safety of single dose oral delafloxacin compared with intramuscular ceftriaxone for uncomplicated gonorrhea treatment: an open-label, non-inferiority, Phase 3, multicenter, randomized study

Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure

Abstract PR006: Initial results of a cohort of advanced pancreatic cancer patients in a phase 1b Study of NGM120, a first-in-class anti-GDNF Family Receptor Alpha Like (GFRAL) antibody

470. Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Patients with Significant Drug Abuse: Outcomes from Global Phase 3 Studies of Delafloxacin (DLX)

2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)

2378. Resolution of Signs and Symptoms (S&S) of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) With Delafloxacin (DLX) IV/Oral Therapy

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-positive (GP) Pathogens

Outcomes with IV/oral Delafloxacin (DLX) Compared with Vancomycin/Aztreonam (VAN/AZ) in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Gram-negative (GN) Pathogens

Comparison of Safety Profile of Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ) in theTreatment of Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI): Integrated Safety Findings from Two Phase III Studies

Impact of Delafloxacin (DLX) and Vancomycin/Aztreonam (VAN/AZ) on Resolution of Signs and Symptoms of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Evaluation of Digital Versus Manual Measures of Lesion Size in a Phase 3 Trial of Delafloxacin (DLX) in Patients With Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

In Vitro Activity of Delafloxacin and Microbiological Response Against Fluoroquinolone Susceptible and Non-Susceptible S. aureus Isolates from Two Phase 3 Studies of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs)

Screening for Hepatitis B Virus Infection in Pregnant Women: US Preventive Services Task Force Reaffirmation Recommendation Statement

Deformation behavior of aluminum alloy 6111-T4

Smart Contact Lenses: Improving the Vision of Millions

Building a Display Field Leader: SKL's Journey

Student Earns Jsid Award For Work On Lcs For Ar Applications

Likelihood Transformations and Artificial Mixtures

A Quick Route to Multiple Highly Potent SARS‐CoV‐2 Main Protease Inhibitors

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement

Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

Suchergebnisse filtern